Indian Drug Makers See Benefits In U.S. Obama Administration
This article was originally published in PharmAsia News
Executive Summary
India's pharmas view the newly inaugurated Barack Obama administration in the United States as a good sign for their generics-dominated industry. The country already is the fourth largest generics supplier in the United States, which itself is the world's largest market at $33 billion a year. Indian firms are counting on Obama's promises to cut health care costs, in part by allowing importation of U.S.-approved drugs from other countries and an added emphasis on government coverage of generic versions. Indian pharmaceuticals also look forward to government efforts to remove obstacles they feel branded companies have managed to get put into place, including anti-tariff hurdles. (Click here for more